Allogeneic stem cell transplantation in patients with flt3-itd mutated aml: transplantation in cr1 is the decisive factor for good outcome

ConclusionsAlloSCT should be regarded as the urgency as soon as CR1 is achieved in this subset of AML patients.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research